Albumedix has completed expansion of its commercial-scale manufacturing facility and established new labs, doubling its albumin production capacity. After more than three years of design and construction work, Albumedix has completed the expansion of its Nottingham facility and is now able to manufacture out of this site. The expansion enables the firm to more than double its albumin production, which is used for stabilization and to deliver pharmaceuticals. “Part of the expansion included the construction of a four-storey building adjacent…
Friday, April 16, 2021 Daily Archives
BPI West: Modular tech key to rapid COVID-19 vaccine development
The coronavirus pandemic has underlined the benefits of modular manufacturing according to an expert who says the approach has been key to accelerating vaccine production. SARS-CoV-2, the virus that causes COVID-19, was first isolated in December 2019 and sequenced a month later. The first vaccines against it were developed, tested, and approved about a year after the first was identified. The record speed with which industry created the COVID-19 shots is testament to vaccine industry efforts, according to John Yoshi…